Follow
Adelina Orellana
Adelina Orellana
Cap de Laboratori C3. ACE Alzheimer Center
Verified email at fundacioace.com
Title
Cited by
Cited by
Year
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
21692019
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
8582022
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
I De Rojas, S Moreno-Grau, N Tesi, B Grenier-Boley, V Andrade, ...
Nature communications 12 (1), 3417, 2021
1732021
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ ACE project
S Moreno‐Grau, I De Rojas, I Hernández, I Quintela, L Montrreal, ...
Alzheimer's & Dementia 15 (10), 1333-1347, 2019
1332019
Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum
WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ...
JAMA neurology 79 (3), 228-243, 2022
1142022
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the …
SJ Van Der Lee, OJ Conway, I Jansen, MM Carrasquillo, L Kleineidam, ...
Acta neuropathologica 138, 237-250, 2019
1032019
Alzheimer Disease Genetics Consortium (ADGC); European Alzheimer’s Disease Initiative (EADI); Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE …
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nat Genet 51 (3), 414-430, 2019
742019
New insights on the genetic etiology of Alzheimer’s and related dementia
C Bellenguez, F Küçükali, I Jansen, V Andrade, S Moreno-Grau, N Amin, ...
MedRxiv, 2020.10. 01.20200659, 2020
712020
Visual impairment in aging and cognitive decline: experience in a Memory Clinic
M Marquié, M Castilla-Martí, S Valero, J Martínez, D Sánchez, ...
Scientific reports 9 (1), 8698, 2019
522019
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study
H Saddiki, A Fayosse, E Cognat, S Sabia, S Engelborghs, D Wallon, ...
PLoS Medicine 17 (8), e1003289, 2020
512020
Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
N Roberto, MJ Portella, M Marquié, M Alegret, I Hernández, A Mauleón, ...
Scientific reports 11 (1), 6448, 2021
492021
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
L Kleineidam, V Chouraki, T Próchnicki, SJ van Der Lee, ...
Acta neuropathologica 139, 1025-1044, 2020
462020
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ...
Alzheimer's research & therapy 10, 1-12, 2018
442018
Highly efficient production of GFP and its derivatives in insect cells for visual in vitro applications
C Oker-Blom, A Orellana, K Keinanen
FEBS letters 389 (3), 238-243, 1996
441996
Use of genetically engineered lipid-tagged antibody to generate functional europium chelate-loaded liposomes Application in fluoroimmunoassay
ML Laukkanen, A Orellana, K Keinänen
Journal of immunological methods 185 (1), 95-102, 1995
411995
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
IE Jansen, SJ van der Lee, D Gomez-Fonseca, I de Rojas, MC Dalmasso, ...
Acta Neuropathologica 144 (5), 821-842, 2022
402022
Use of proteoliposomes to generate phage antibodies against native AMPA receptor
LK Jespersen, A Kuusinen, A Orellana, K Keinänen, J Engberg
European Journal of Biochemistry 267 (5), 1382-1389, 2000
382000
Covalent binding of urease on ammonium-selective potentiometric membranes
MH Gil, AP Piedade, S Alegret, J Alonso, E Martinez-Fabregas, ...
Biosensors and Bioelectronics 7 (9), 645-652, 1992
381992
Novel triazolopyridylbenzamides as potent and selective p38α inhibitors
J Aiguadé, C Balagué, I Carranco, F Caturla, M Domínguez, P Eastwood, ...
Bioorganic & medicinal chemistry letters 22 (10), 3431-3436, 2012
372012
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy …
S Moreno–Grau, O Rodríguez‐Gómez, A Sanabria, A Pérez‐Cordón, ...
Alzheimer's & Dementia 14 (5), 634-643, 2018
352018
The system can't perform the operation now. Try again later.
Articles 1–20